Vertiv Holdings Co · VRT · FY2025 Q2 · Calendar Q3 2025
Vertiv raises FY2025 outlook as AI infrastructure demand drives Q2 growth
Vertiv's Q2 analysis supports a growth case built on rising demand for AI data-center infrastructure, stronger orders and an expanded product offering. The counterweight is execution: tariff costs, rapid capacity expansion and regional growth differences could constrain margins or delay conversion of demand into results.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about VRT FY2025 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with Q1, management's Q2 analysis showed continued demand strength, with organic sales up 34% year over year, orders up 15% and book-to-bill at 1.2×. The company raised its full-year outlook for revenue, adjusted EPS and free cash flow, while tariff-related margin pressure and operational inefficiencies remained unresolved near-term issues.
Guidance delta
Management raised full-year net sales guidance to $10 billion, adjusted EPS guidance to $3.80 and free cash flow guidance to $1.4 billion. In Q1, it had raised organic sales growth guidance to 18% and increased its top-line forecast while maintaining its adjusted EPS estimate.
Key takeaways
- Q2 sales and orders reflected strong demand, particularly for data-center and AI infrastructure.
- Higher rack density, white-space integration and modular prefabrication are central growth opportunities.
- Tariffs and rapid capacity expansion remain near-term margin and execution risks.
Management priorities
- Increase engineering, research and development, and capacity investment.
- Integrate Great Lakes and expand U.S. and European manufacturing capacity.
- Scale SmartRun modular prefabrication and deepen collaborations with CoreWeave, Dell, NVIDIA and Oklo.
Follow VRT with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| GLJ Research | Sell | Sell | Maintain | Nov 2, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 29, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 29, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 29, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Oct 29, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 12, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | May 21, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 15, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 15, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 24, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 23, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 14, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 9, 2025 |
| UBS | Buy | Buy | Maintain | Oct 23, 2025 |
| Roth Capital | Buy | Buy | Maintain | Oct 21, 2025 |
| Melius Research | Buy | Hold | Upgrade | Jul 8, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 14, 2023 |
| Vertical Research | Buy | Hold | Upgrade | Jun 9, 2023 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Oct 27, 2022 |
| Guggenheim | Buy | Buy | Maintain | Nov 12, 2020 |
Named analyst price targets
Upside is calculated against the persisted current price $239.22. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BMO Capital | Daniel DiCicco | $331 | $248.41 | +38.4% | Oct 29, 2026 |
| Cowen & Co. | Analyst unavailable | $357 | $249.57 | +49.2% | Oct 29, 2026 |
| RBC Capital | Jeffrey Reive | $351 | $248.56 | +46.7% | Oct 29, 2026 |
| Bernstein | Analyst unavailable | $376 | $242.88 | +57.2% | Oct 29, 2026 |
| Roth Capital | Analyst unavailable | $345 | $242.94 | +44.2% | Oct 29, 2026 |
| Mizuho Securities | Brett Linzey | $300 | $242.94 | +25.4% | Oct 29, 2026 |
| Wells Fargo | Stephen Tusa | $345 | $242.94 | +44.2% | Oct 29, 2026 |
| Morgan Stanley | Analyst unavailable | $330 | $209.56 | +37.9% | Oct 16, 2026 |
| BMO Capital | Analyst unavailable | $329 | $252.18 | +37.5% | Oct 4, 2026 |
| Wells Fargo | Stephen Tusa | $340 | $245.3 | +42.1% | Sep 24, 2026 |
| GLJ Research | Analyst unavailable | $381 | $275.17 | +59.3% | Aug 7, 2026 |
| Bernstein | Varun Govindaraj | $368 | $242.93 | +53.8% | Jul 31, 2026 |
| UBS | Amit Mehrotra | $370 | $228.56 | +54.7% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $320 | $233.42 | +33.8% | Jul 30, 2026 |
| RBC Capital | Analyst unavailable | $337 | $237.54 | +40.9% | Jul 30, 2026 |
| Oppenheimer | Noah Kaye | $325 | $237.53 | +35.9% | Jul 30, 2026 |
| Evercore ISI | Analyst unavailable | $375 | $228.96 | +56.8% | Jul 29, 2026 |
| Piper Sandler | Analyst unavailable | $375 | $233.92 | +56.8% | Jul 29, 2026 |
| KeyBanc | Analyst unavailable | $360 | $301.16 | +50.5% | Jul 23, 2026 |
| RBC Capital | Analyst unavailable | $418 | $294 | +74.7% | Jul 16, 2026 |
| Robert W. Baird | Luke Junk | $370 | $304.57 | +54.7% | Jul 15, 2026 |
| Bernstein | Analyst unavailable | $416 | $289.52 | +73.9% | Jun 9, 2026 |
| Roth Capital | Justin Clare | $355 | $328.36 | +48.4% | May 21, 2026 |
| Oppenheimer | Noah Kaye | $353 | $315.67 | +47.6% | May 21, 2026 |
| Mizuho Securities | Brett Linzey | $380 | $315.67 | +58.8% | May 21, 2026 |
| RBC Capital | Deane Dray | $435 | $364.5 | +81.8% | May 15, 2026 |
| Barclays | Analyst unavailable | $412 | $376.23 | +72.2% | May 15, 2026 |
| Loop Capital Markets | Analyst unavailable | $500 | $376.23 | +109.0% | May 14, 2026 |
| Evercore ISI | Analyst unavailable | $425 | $357.43 | +77.7% | May 12, 2026 |
| Morgan Stanley | Analyst unavailable | $350 | $323.7 | +46.3% | Apr 23, 2026 |
| Oppenheimer | Analyst unavailable | $330 | $323.86 | +37.9% | Apr 23, 2026 |
| Cowen & Co. | Analyst unavailable | $347 | $316.09 | +45.1% | Apr 23, 2026 |
| RBC Capital | Analyst unavailable | $356 | $317 | +48.8% | Apr 23, 2026 |
| Barclays | Analyst unavailable | $345 | $305.14 | +44.2% | Apr 23, 2026 |
| Evercore ISI | Analyst unavailable | $350 | $308.21 | +46.3% | Apr 20, 2026 |
| Roth Capital | Analyst unavailable | $335 | $301.16 | +40.0% | Apr 16, 2026 |
| BNP Paribas | Analyst unavailable | $345 | $299.96 | +44.2% | Apr 14, 2026 |
| Morgan Stanley | Analyst unavailable | $285 | $238.08 | +19.1% | Feb 13, 2026 |
| Oppenheimer | Analyst unavailable | $270 | $253.99 | +12.9% | Feb 12, 2026 |
| Goldman Sachs | Mark Delaney | $277 | $252.86 | +15.8% | Feb 12, 2026 |
| Barclays | Julian Mitchell | $281 | $252.69 | +17.5% | Feb 12, 2026 |
| RBC Capital | Deane Dray | $266 | $251.72 | +11.2% | Feb 12, 2026 |
| Roth Capital | Analyst unavailable | $275 | $248.51 | +15.0% | Feb 12, 2026 |
| Mizuho Securities | Brett Linzey | $290 | $248.51 | +21.2% | Feb 12, 2026 |
| Deutsche Bank | Analyst unavailable | $281 | $248.51 | +17.5% | Feb 12, 2026 |
| Evercore ISI | Analyst unavailable | $280 | $245.22 | +17.0% | Feb 11, 2026 |
| RBC Capital | Analyst unavailable | $200 | $176.96 | -16.4% | Jan 15, 2026 |
| Barclays | Julian Mitchell | $200 | $162.01 | -16.4% | Jan 2, 2026 |
| Goldman Sachs | Analyst unavailable | $204 | $185.61 | -14.7% | Dec 9, 2025 |
| Barclays | Analyst unavailable | $181 | $178.88 | -24.3% | Dec 4, 2025 |
| Cowen & Co. | Michael Elias | $211 | $177.86 | -11.8% | Dec 1, 2025 |
| Cowen & Co. | Michael Elias | $210 | $183.43 | -12.2% | Oct 23, 2025 |
| RBC Capital | Analyst unavailable | $196 | $180.95 | -18.1% | Oct 23, 2025 |
| UBS | Analyst unavailable | $201 | $171.59 | -16.0% | Oct 23, 2025 |
| Oppenheimer | Analyst unavailable | $195 | $171.59 | -18.5% | Oct 23, 2025 |
| Morgan Stanley | Christopher Snyder | $200 | $180.74 | -16.4% | Oct 23, 2025 |
| Goldman Sachs | Analyst unavailable | $182 | $171.59 | -23.9% | Oct 23, 2025 |
| Barclays | Analyst unavailable | $170 | $171.59 | -28.9% | Oct 23, 2025 |
| Roth Capital | Analyst unavailable | $195 | $175.73 | -18.5% | Oct 21, 2025 |
| Mizuho Securities | Analyst unavailable | $198 | $177.82 | -17.2% | Oct 17, 2025 |
| Deutsche Bank | Nicole Deblase | $216 | $175.15 | -9.7% | Oct 15, 2025 |
| Oppenheimer | Noah Kaye | $190 | $179 | -20.6% | Oct 14, 2025 |
| Barclays | Analyst unavailable | $145 | $150.86 | -39.4% | Oct 1, 2025 |
| Goldman Sachs | Analyst unavailable | $159 | $138.62 | -33.5% | Sep 29, 2025 |
| Oppenheimer | Noah Kaye | $151 | $145.6 | -36.9% | Jul 31, 2025 |
| Barclays | Analyst unavailable | $128 | $144.17 | -46.5% | Jul 31, 2025 |
| Mizuho Securities | Brett Linzey | $150 | $124.21 | -37.3% | Jul 16, 2025 |
| Wolfe Research | Nigel Coe | $155 | $120.72 | -35.2% | Jul 10, 2025 |
| UBS | Amit Mehrotra | $155 | $71.46 | -35.2% | Nov 13, 2024 |
| Cowen & Co. | Lance Vitanza | $115 | $110.03 | -51.9% | Oct 24, 2024 |
| Mizuho Securities | Brett Linzey | $125 | $109.72 | -47.7% | Oct 24, 2024 |
| Oppenheimer | Noah Kaye | $121 | $108.36 | -49.4% | Oct 24, 2024 |
| Evercore ISI | Amit Daryanani | $135 | $108.36 | -43.6% | Oct 23, 2024 |
| Cowen & Co. | Michael Elias | $93 | $95.98 | -61.1% | Sep 23, 2024 |
| Bank of America Securities | Andrew Obin | $115 | $76.99 | -51.9% | Sep 3, 2024 |
| Mizuho Securities | Brett Linzey | $92 | $69.27 | -61.5% | Aug 7, 2024 |
| Evercore ISI | Amit Daryanani | $105 | $95.31 | -56.1% | Jun 14, 2024 |
| Oppenheimer | Noah Kaye | $98 | $84.57 | -59.0% | Apr 25, 2024 |
| Wolfe Research | Nigel Coe | $97 | $85.34 | -59.5% | Apr 8, 2024 |
| Oppenheimer | Noah Kaye | $96 | $80.69 | -59.9% | Apr 4, 2024 |
| Wolfe Research | Nigel Coe | $94 | $81.01 | -60.7% | Mar 28, 2024 |
| Evercore ISI | Amit Daryanani | $80 | $73.37 | -66.6% | Mar 13, 2024 |
| Citigroup | Analyst unavailable | $18 | $13.64 | -92.5% | Dec 9, 2022 |
| Cowen & Co. | Lance Vitanza | $20 | $14.79 | -91.6% | Oct 27, 2022 |
| Mizuho Securities | Brett Linzey | $10 | $11.9 | -95.8% | Oct 4, 2022 |
| Goldman Sachs | Analyst unavailable | $17 | $12.65 | -92.9% | Aug 4, 2022 |
| Deutsche Bank | Analyst unavailable | $15 | $8.46 | -93.7% | Jul 13, 2022 |
| Goldman Sachs | Analyst unavailable | $15 | $10.99 | -93.7% | Jun 1, 2022 |
Track every rating change on VRT the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationVertiv Holdings Co, headquartered in Columbus, Ohio, is a global provider of essential digital infrastructure technologies and comprehensive lifecycle services. The company specializes in the design, manufacturing, and servicing of critical systems vital for data centers, communication networks, and diverse commercial and industrial applications. Its extensive product range encompasses AC and DC power management, thermal control solutions, integrated rack systems, modular designs, and sophisticated management platforms for monitoring and governing digital environments. These solutions are fundamental to the operation of numerous modern services, including e-commerce, online banking, file sharing, video on-demand, energy storage, wireless communications, the Internet of Things, and online gaming.…
Historical context
All VRT earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| RYAAY Ryanair Holdings plc | FY2027 Q2 · Calendar Q4 2026 | -0.3% | +2.9% | Ryanair flags fuel-cost pressure while maintaining growth plans |
| BWXT BWX Technologies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +6.8% | -0.2% | BWXT: Q3 growth and raised cash-flow outlook reinforce nuclear expansion |
| GD General Dynamics Corporation | FY2026 Q3 · Calendar Q4 2026 | +9.0% | +0.5% | General Dynamics raises outlook as orders and backlog surge |
| RBC RBC Bearings Incorporated | FY2027 Q2 · Calendar Q4 2026 | +5.9% | -6.8% | RBC Bearings: Strong Q2, capacity investment supports second half |
| CNI Canadian National Railway Company | FY2026 Q3 · Calendar Q4 2026 | +3.4% | -0.3% | CN posts strong Q3, maintains EPS outlook and expands Mexico strategy |
| NVT nVent Electric plc | FY2026 Q3 · Calendar Q4 2026 | +8.6% | -8.8% | nVent raises outlook as data-center demand and Maverick broaden growth |
Latest beats and misses
Who reports nextBeat on EPS
- TSEMFY2026 Q3 · November 2, 2026+7.5% EPS-6.7% move
- CLXFY2027 Q1 · November 2, 2026+44.9% EPS+2.2% move
- AAPLFY2026 Q4 · November 2, 2026+3.0% EPS-1.8% move
- PLTRFY2026 Q3 · November 2, 2026+8.3% EPS-3.1% move
- ETRFY2026 Q3 · November 2, 2026+14.5% EPS-0.2% move
- OFY2026 Q3 · November 2, 2026+5.7% EPS+1.1% move
Missed on EPS
- VRTXFY2026 Q3 · November 2, 2026-1.2% EPS-1.0% move
- PEGFY2026 Q3 · November 2, 2026-3.4% EPS+0.1% move
- RYAAYFY2027 Q2 · November 2, 2026-0.3% EPS+2.9% move
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
- CCJFY2026 Q3 · October 30, 2026-101.4% EPS-7.9% move
Get the VRT recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
- Polygon adjusted daily market bars · 2026-11-03T15:00:48.476754+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T15:00:48.472965+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.